Scientific opinion on an application for renewal of authorisation for continued marketing of maize 59122 and derived food and feed submitted under articles 11 and 23 of Regulation (EC) No 1829/2003 by Pioneer Overseas Corporation and Dow AgroSciences LLC by Naegeli, Hanspeter et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Scientific opinion on an application for renewal of authorisation for
continued marketing of maize 59122 and derived food and feed submitted
under articles 11 and 23 of Regulation (EC) No 1829/2003 by Pioneer
Overseas Corporation and Dow AgroSciences LLC
Naegeli, Hanspeter; Birch, Andrew Nicholas; Casacuberta, Josep; De Schrijver, Adinda; Gralak, Mikołaj
Antoni; Guerche, Philippe; Jones, Huw; Manachini, Barbara; Messéan, Antoine; Nielsen, Elsa Ebbesen;
Nogué, Fabien; Robaglia, Christophe; Rostoks, Nils; Sweet, Jeremy; Tebbe, Christoph; Visioli,
Francesco; Wal, Jean‐Michel; Álvarez, Fernando; Ardizzone, Michele; Paraskevopoulos, Kostas
Abstract: Following the submission of application EFSA-GMO-RX-003 under Regulation (EC) No
1829/2003 from Pioneer Overseas Corporation and Dow AgroSciences LLC, the Panel on Genetically
Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scien-
tific risk assessment on the data submitted in the context of the renewal of authorisation application of
the insect-resistant genetically modified maize 59122. The data received in the context of this renewal
application contained post-market environmental monitoring reports, a systematic search and evaluation
of literature, updated bioinformatics analyses, and additional documents or studies performed by or on
behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure
or new scientific uncertainties identified during the authorisation period and not previously assessed in
the context of the original application. Under the assumption that the DNA sequence of the event in
maize 59122 considered for renewal is identical to the corrected sequence of the originally assessed event,
the GMO Panel concludes that no new hazards or modified exposure and no new scientific uncertainties
were identified that would change the conclusions of the original risk assessment on maize 59122. (C)
2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
DOI: https://doi.org/10.2903/j.efsa.2017.4861
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-144688
Published Version
 
 
Originally published at:
Naegeli, Hanspeter; Birch, Andrew Nicholas; Casacuberta, Josep; De Schrijver, Adinda; Gralak, Mikołaj
Antoni; Guerche, Philippe; Jones, Huw; Manachini, Barbara; Messéan, Antoine; Nielsen, Elsa Ebbesen;
Nogué, Fabien; Robaglia, Christophe; Rostoks, Nils; Sweet, Jeremy; Tebbe, Christoph; Visioli, Francesco;
Wal, Jean‐Michel; Álvarez, Fernando; Ardizzone, Michele; Paraskevopoulos, Kostas (2017). Scientific
opinion on an application for renewal of authorisation for continued marketing of maize 59122 and derived
food and feed submitted under articles 11 and 23 of Regulation (EC) No 1829/2003 by Pioneer Overseas
Corporation and Dow AgroSciences LLC. EFSA Journal, 15(6):e04861.
DOI: https://doi.org/10.2903/j.efsa.2017.4861
2
SCIENTIFIC OPINION
ADOPTED: 18 May 2017
doi: 10.2903/j.efsa.2017.4861
Scientiﬁc opinion on an application for renewal of
authorisation for continued marketing of maize 59122 and
derived food and feed submitted under articles 11 and 23 of
Regulation (EC) No 1829/2003 by Pioneer Overseas
Corporation and Dow AgroSciences LLC
EFSA Panel on Genetically Modiﬁed Organisms (GMO),
Hanspeter Naegeli, Andrew Nicholas Birch, Josep Casacuberta, Adinda De Schrijver,
Mikołaj Antoni Gralak, Philippe Guerche, Huw Jones, Barbara Manachini, Antoine Messean,
Elsa Ebbesen Nielsen, Fabien Nogue, Christophe Robaglia, Nils Rostoks, Jeremy Sweet,
Christoph Tebbe, Francesco Visioli, Jean-Michel Wal, Fernando Alvarez, Michele Ardizzone and
Kostas Paraskevopoulos
Abstract
Following the submission of application EFSA-GMO-RX-003 under Regulation (EC) No 1829/2003 from
Pioneer Overseas Corporation and Dow AgroSciences LLC, the Panel on Genetically Modiﬁed Organisms
of the European Food Safety Authority (GMO Panel) was asked to deliver a scientiﬁc risk assessment
on the data submitted in the context of the renewal of authorisation application of the insect-resistant
genetically modiﬁed maize 59122. The data received in the context of this renewal application
contained post-market environmental monitoring reports, a systematic search and evaluation of
literature, updated bioinformatics analyses, and additional documents or studies performed by or on
behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modiﬁed
exposure or new scientiﬁc uncertainties identiﬁed during the authorisation period and not previously
assessed in the context of the original application. Under the assumption that the DNA sequence of
the event in maize 59122 considered for renewal is identical to the corrected sequence of the originally
assessed event, the GMO Panel concludes that no new hazards or modiﬁed exposure and no new
scientiﬁc uncertainties were identiﬁed that would change the conclusions of the original risk
assessment on maize 59122.
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
Keywords: maize, 59122, renewal, articles 11 and 23, Regulation (EC) No 1829/2003
Requestor: European Commission (DG SANTE)
Question number: EFSA-Q-2016-00526
Correspondence: GMO@efsa.europa.eu
EFSA Journal 2017;15(6):4861www.efsa.europa.eu/efsajournal
Panel members: Andrew Nicholas Birch, Josep Casacuberta, Adinda De Schrijver, Mikołaj Antoni
Gralak, Philippe Guerche, Huw Jones, Barbara Manachini, Antoine Messean, Hanspeter Naegeli, Elsa
Ebbesen Nielsen, Fabien Nogue, Christophe Robaglia, Nils Rostoks, Jeremy Sweet, Christoph Tebbe,
Francesco Visioli and Jean-Michel Wal.
Acknowledgements: The Panel wishes to thank the members of its standing Working Groups on
Molecular Characterisation, Food/Feed and Environmental Risk Assessment for the preparatory work on
this scientiﬁc opinion.
Suggested citation: EFSA GMO Panel (EFSA Panel on genetically modiﬁed organisms), Naegeli H,
Birch AN, Casacuberta J, De Schrijver A, Gralak MA, Guerche P, Jones H, Manachini B, Messean A,
Nielsen EE, Nogue F, Robaglia C, Rostoks N, Sweet J, Tebbe C, Visioli F, Wal J-M, Alvarez F, Ardizzone M
and Paraskevopoulos K, 2017. Scientiﬁc opinion on an application for renewal of authorisation for
continued marketing of maize 59122 and derived food and feed submitted under articles 11 and 23 of
Regulation (EC) No 1829/2003 by Pioneer Overseas Corporation and Dow AgroSciences LLC. EFSA
Journal 2017;15(6):4861, 10 pp. https://doi.org/10.2903/j.efsa.2017.4861
ISSN: 1831-4732
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
This is an open access article under the terms of the Creative Commons Attribution-NoDerivs License,
which permits use and distribution in any medium, provided the original work is properly cited and no
modiﬁcations or adaptations are made.
The EFSA Journal is a publication of the European Food
Safety Authority, an agency of the European Union.
Scientiﬁc opinion on a renewal application for maize 59122
www.efsa.europa.eu/efsajournal 2 EFSA Journal 2017;15(6):4861
Summary
Following the submission of application EFSA-GMO-RX-003 under Regulation (EC) No 1829/20031
from Pioneer Overseas Corporation and Dow AgroSciences LLC, the Panel on Genetically Modiﬁed
Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientiﬁc opinion
on the data submitted in the context of the renewal of authorisation application of the insect resistant
genetically modiﬁed (GM) maize 59122. The scope of the renewal application EFSA-GMO-RX-003 is for
food and feed uses, import and processing, but excludes cultivation within the European Union (EU).
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-RX-003,
additional information provided by the applicant, scientiﬁc comments submitted by the Member States
and relevant scientiﬁc publications. The data received in the context of the renewal application
EFSA-GMO-RX-003 contained: post-market environmental monitoring reports, an evaluation of the
literature retrieved by a systematic search, updated bioinformatics analyses, and additional documents
or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible
new hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation
period and not previously assessed in the context of the original application.
In conclusion, under the assumption that the DNA sequence of the event in maize 59122
considered for renewal is identical to the corrected sequence of the originally assessed event, the GMO
Panel concludes that no new hazards or modiﬁed exposure and no new scientiﬁc uncertainties were
identiﬁed that would change the conclusions of the original risk assessment on maize 59122 (EFSA,
2007).
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
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1. Introduction
1.1. Background
On 4 August 2016, the European Food Safety Authority (EFSA) received from the European
Commission (DG SANTE) application EFSA-GMO-RX-003 for the renewal of authorisation of genetically
modiﬁed (GM) maize 59122 (maize DAS-59122-7) for food and feed uses, import and processing
submitted by Pioneer Overseas Corporation and Dow AgroSciences LLC within the framework of
Regulation (EC) No 1829/2003. Before sending the application to EFSA, the European Commission (DG
SANTE) checked whether the data submitted in the context of this renewal application were in line
with the legal requirements laid down in Articles 11 and 23 of Regulation (EC) No 1829/2003.
After receiving the application EFSA-GMO-RX-003, and in accordance with Articles 5(2)(b) and 17(2)
(b) of Regulation (EC) No 1829/2003, EFSA informed Member States and made the summary of the
application available to the public on the EFSA website.2
On 16 September 2016, EFSA declared the application valid in accordance with Articles 6(1) and 18
(1) of Regulation (EC) No 1829/2003. EFSA made the valid application available to Member States and
the European Commission, and consulted nominated risk assessment bodies of Member States,
including national Competent Authorities within the meaning of Directive 2001/18/EC following the
requirements of Articles 6(4) and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc
opinion. Member States had 3 months after the opening of the Member State commenting period
(until 19 December 2016) to make their opinion known.
Following the submission of application EFSA-GMO-NL-2005-12 and the publication of the EFSA
scientiﬁc opinion (EFSA, 2007), the placing on the market of maize 59122 for food/feed uses, except
cultivation, was authorised by Commission Decision 2007/702/EC.3 A copy of this authorisation was
provided by the applicant.4
EFSA requested additional information on 24 October 2016 and 29 November 2016, and the
applicant submitted it on 23 January 2017 and 26 January 2017, respectively.
In giving its scientiﬁc opinion to the European Commission, the Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application.
As additional information was requested by the GMO Panel, the time limit of 6 months was extended
accordingly, in line with Articles 6(1), 6(2), 18(1) and 18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc risk assessment on the data submitted in the
context of a renewal of authorisation application for maize 59122 for food and feed uses, import and
processing in accordance with Articles 11 and 23 of Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of genetically modiﬁed
organisms (GMOs) or food/feed containing or consisting of GMOs, conditions for the protection of
particular ecosystems/environment and/or geographical areas should be indicated in accordance with
Articles 6(5)(e) and 18(5)(e) of Regulation (EC) No 1829/2003.
The GMO Panel was not requested to give an opinion on information required under Annex II to
the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation event in
the food/feed and/or food/feed produced from it), which are matters related to risk management.
2 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2016-00526
3 Commission Decision of 24 October 2007 authorising the placing on the market of products containing, consisting of, or
produced from genetically modiﬁed maize 59122 (DAS-59122-7) pursuant to Regulation (EC) No 1829/2003 of the European
Parliament and of the Council. OJ L 285, 31.10.2007, p. 42-46.
4 Dossier: Part II – Section 1.
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2. Data and methodologies
2.1. Data
The data for application EFSA-GMO-RX-003 submitted by the applicant at the time of submission, or
in reply to requests for additional information, are speciﬁed below.
The applicant clariﬁed that the 59122 event sequence considered in the context of this renewal
application was the sequence submitted in the original application EFSA-GMO-NL-2005-12 (EFSA, 2007),
but corrected for sequencing errors affecting three single nucleotides5 (EFSA GMO Panel, 2016).
According to the EFSA guidelines for renewal of applications of GM food and feed authorised under
Regulation (EC) No 1829/2003 (EFSA GMO Panel, 2015), the GMO Panel evaluated the data provided
in the context of this maize 59122 renewal application under the assumption that the event sequence
is identical to the corrected sequence that was newly determined and reported in this application.
2.1.1. Post-market monitoring reports6
Based on the outcome of the initial food and feed risk assessment, a post-market monitoring plan
for monitoring of GM food/feed was not required by the authorising decisions. The implementation of
a post-market environmental monitoring (PMEM) plan, consisting of a general surveillance plan to
check for any adverse effects on the environment arising from maize 59122, was a condition for the
authorisation. As no potential adverse environmental effects were identiﬁed in the environmental risk
assessment (ERA) of maize 59122 (EFSA, 2007), case-speciﬁc monitoring was not considered
necessary by the GMO Panel.
The applicant provided eight annual PMEM reports covering a reporting period from October 2007 to
June 2015 and an update as of June 2016. The annual PMEM plans submitted by the applicant included
(1) the description of a centralised system established by EuropaBio for the collection of information
recorded by various operators (federations involved in maize (or bulk grain) import and processing) on
any observed adverse effect(s) of the GMO on human health and the environment arising from
handling of maize 59122; (2) the reports of the surveillance activities conducted by such operators; and
(3) the review of relevant scientiﬁc peer-reviewed studies retrieved from literature searches.
The applicant provided an overall assessment of the general surveillance activities in the renewal
dossier.
2.1.2. Systematic search and evaluation of literature7
In addition to the literature searches submitted within the annual PMEM reports, the applicant
conducted an additional search, covering the complete duration of the event’s authorisation (from
2007 to 2016), and following the principles outlined in the EFSA guidance on the application of
systematic review methodology for food and feed safety assessment (EFSA, 2010).
The applicant performed a systematic search on 6 April 2016 of studies related to maize 59122
covering the authorisation period. The applicant used the databases Scopus and CAB Direct to identify
relevant studies. Eligibility/inclusion criteria were deﬁned a priori to categorise the relevance of
retrieved studies. The search terms used included truncation symbols, synonyms, scientiﬁc and
common names, brand and generic names and British and US variants (e.g. maize and corn) and were
combined using the Boolean operators ‘OR’ and ‘AND’. No restrictions (e.g. language, publication type)
were applied with the exception of the time period. Altogether 458 unique studies were retrieved.
After applying the eligibility/inclusion criteria, the applicant identiﬁed 11 relevant primary research
studies published between 2007 and 2016.
2.1.3. Updated bioinformatics8
At the time of submission of the renewal dossier, the applicant provided a bioinformatics package
for maize 59122 based on the corrected maize 59122 event sequence including the inserted
sequences and sequences ﬂanking the inserts. The data package included the analysis of (1) the
potential disruption of any known maize genes by the 59122 insert; (2) the similarity of the newly
5 Additional information: 23/1/2017.
6 Dossier: Part II – Section 2.
7 Dossier: Part II – Section 3.2.1.
8 Dossier: Part II – Section 3.2.2 and Annex 11.
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expressed proteins or any other open reading frame (ORF) deﬁned from stop-to-stop codon, present
within the insert or spanning the junction sites to known allergens or toxins; and (3) the insert
containing any sequences of bacterial origin that would facilitate horizontal gene transfer (HGT) to
microorganisms by homologous recombination.
2.1.4. Additional documents or studies provided by the applicant9
In line with the renewal guidance requirements (EFSA GMO Panel, 2015), the applicant provided an
overview on the worldwide approvals of maize 59122, and a list and a summary of all unpublished
studies produced, controlled or sponsored by the applicant, provided to the applicant by a third party,
or performed over the course of the authorisation period and not previously submitted to the EU
(Table 1). The relevance of the listed studies for molecular characterisation, human and animal safety
and the environment was assessed. Based on the information provided, the GMO Panel requested
from the applicant on 29 November 2016 the full study reports of three comparative analysis and ﬁve
food and feed safety-related studies. The applicant submitted the requested information on 26 January
2017 and the study reports were assessed by the GMO Panel.
Table 1: List of all additional studies performed by Pioneer Overseas Corporation or Dow
Agrosciences LLC over the course of the authorisation period (2007–2016) with regard to
the evaluation of the safety of the food/feed and the risks of the food/feed to humans,
animal or the environment from maize 59122
Study identiﬁcation Title
PHI-R035-Y15(a) Segregation analysis of four maize generations containing event DAS-59122-7
PHI-2004-022/702(a) Expressed trait protein concentration of a maize line containing event DAS-59122-7:
U.S. and Canada test sites
PHI-2015-062(a) Characterization of PAT protein derived from a microbial expression system
PHI-2004-022/701(a),(c) Agronomic characteristics of a maize line containing event DAS-59122-7: U.S. and
Canada test sites
PHI-2009-042/001(a),(c) Agronomic characteristics of maize lines containing events DP-Ø9814Ø-6, DAS-Ø15Ø7-1,
or DAS-59122-7: Europe test sites
PHI-2004-022/700(a),(c) Nutrient composition of a maize line containing event DAS-59122-7: U.S. and Canada
test sites
PHI-2015-055(a),(c) Cry34Ab1 and Cry35Ab1 combination: acute oral toxicity study in mice
PHI-2015-059(a),(c) Cry34Ab1: Acute oral toxicity study in mice
PHI-2015-060(a),(c) Cry35Ab1: Acute oral toxicity study in mice
PHI-2015-074(a),(c) PAT: Acute oral toxicity study in mice
PHI-2005-118(a) Evaluation of nutritional equivalency of Herculex* RW corn grain in the diets of beef
steers
PHI-2003-016(a) Chile ﬁeld production of grain from maize lines containing event: DAS-59122-7
PHI-2003-066(a) Plant growth and tissue sample collection for developing seed and leaf tissue from
event DAS-59122-7 and control plants
PHI-2004-029(a) U.S. ﬁeld production of grain from maize line containing event: DAS-59122-7
PHI-2004-093(a) Field production of grain from hybrid maize line DAS-59122-7: Chile
PHI-2005-028(a) Field production of grain and silage from maize line 59122
PHI-2005-064(a) Field production of grain from hybrid maize line 59122
120936(b),(c) In vitro simulated intestinal ﬂuid digestibility study of phosphinothricin acetyltransferase
(PAT) protein
050072(b) Quantiﬁcation of Cry34Ab1 and Cry35Ab1 Proteins in Wet-Milling and Dry-Milling
Corn Processed Products by Enzyme-Linked Immunosorbent Assay (ELISA)
(a): Performed by Pioneer Hi-Bred International, Inc.
(b): Performed by Dow Agrosciences.
(c): Studies for which the full report was requested by the GMO Panel.
9 Dossier: Part II – Sections 2.3.1.1, 3.1 and additional information: 26/1/2017.
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2.1.5. Overall assessment as provided by the applicant10
In line with the requirements listed in the renewal guidance (EFSA GMO Panel, 2015), the applicant
provided an overall assessment on whether the collected information leads to the identiﬁcation of new
hazards or modiﬁed exposure, or adds new scientiﬁc uncertainties.
2.1.6. Monitoring plan and proposal for improving the conditions of the original
authorisation11
The applicant indicated in the dossier that the environmental monitoring plan is appropriate and
does not need any changes.
2.2. Methodologies
The GMO Panel assessed the data submitted in the context of the renewal of the authorisation
application of maize 59122 for food and feed uses, import and processing in accordance with Articles
11 and 23 of Regulation (EC) No 1829/2003. The GMO Panel took into account the requirements
described in its guideline for the risk assessment of renewal applications of GM food and feed
authorised under Regulation (EC) No 1829/2003 (EFSA GMO Panel, 2015).
The comments raised by Member States are addressed in Annex G of EFSA’s overall opinion12 and
were taken into consideration during the scientiﬁc risk assessment.
3. Assessment
3.1. Evaluation of the post-market environmental monitoring reports
During the general surveillance activities covering the authorisation period of maize 59122, no
adverse effects were reported by the applicant.
3.2. Evaluation of the systematic search and evaluation of literature
Ten of the 11 relevant primary research studies identiﬁed by the applicant have already been
assessed by the GMO Panel (EFSA GMO Panel, 2013) and it was concluded that none of them raised any
safety concerns. The GMO Panel assessed the remaining publication, Ferreira et al. (2015), in which it
was reported that the agronomic and phenotypic characteristics and nutritional composition of grains
and forage of maize 59122 did not differ from its non-GM comparator. The GMO Panel considered that
the study did not give rise to any safety concern for human and animal health and the environment
which would change the original risk assessment conclusions on maize 59122.
3.3. Evaluation of the updated bioinformatics
The results of the bioinformatics analyses on the corrected 59122 event sequence conﬁrmed that
no known endogenous genes were disrupted by the insert. Analyses of the amino acid sequence of the
newly expressed Cry34Ab1, Cry35Ab1 and phosphinothricin acetyltransferase (PAT) proteins revealed
no signiﬁcant similarities to toxins and allergens. In addition, bioinformatics analyses of the newly
created ORFs within the insert or spanning the junctions with genomic DNA revealed no signiﬁcant
similarities to toxins and allergens.
The sequence identity analysis of the regions of bacterial origin in maize 59122 did not identify
elements with sufﬁcient length and identity to support homologous recombination (EFSA, 2015). There
is no information that would change the previous conclusion of the GMO Panel that the unlikely, but
theoretically possible, horizontal transfer of recombinant genes from maize 59122 to bacteria does not
raise any environmental safety concern.
10 Dossier: Part II – Sections 2.3.1.
11 Dossier: Part II – Section 2.5.
12 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2017-00433
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3.4. Evaluation of the additional documents or studies provided by the
applicant
The GMO Panel evaluated the summary and/or the full study reports of the relevant studies
provided (Table 1). This new information did not raise any concern for human and animal health, and
the environment which would change the original risk assessment conclusions on maize 59122.
3.5. Evaluation of the overall assessment as provided by the applicant
The GMO Panel evaluated the overall assessment provided by the applicant and did not identify
new hazards, relevant changes in the exposure to products containing maize 59122 or new scientiﬁc
uncertainties which would change the original risk assessment conclusions of maize 59122.
3.6. Evaluation of the monitoring plan and proposal for improving the
conditions of the original authorisation
The PMEM plan followed by the applicant consists mainly of general surveillance of imported GM
maize plant material, including maize 59122. This general surveillance is coordinated by EuropaBio and
implemented by selected operators (federations involved in maize import and processing). In addition,
the applicant reviews relevant scientiﬁc publications retrieved from literature searches on an annual
basis. As mentioned in Section 2.1.6, the applicant considers that this plan does not need any
changes. The GMO Panel is of the opinion that the scope of the plan provided by the applicant is
consistent with the scope of maize 59122 but notes that monitoring is related to risk management,
and thus the ﬁnal adoption of the PMEM plan falls outside the mandate of EFSA.
4. Conclusions
Under the assumption that the DNA sequence of the event in maize 59122 considered for renewal
is identical to the corrected sequence of the originally assessed event, the GMO Panel concludes that
no new hazards or modiﬁed exposure and no new scientiﬁc uncertainties were identiﬁed for the
application for renewal that would change the conclusions of the original risk assessment on
maize 59122 (EFSA, 2007).
Documentation provided to EFSA
1) Letter from the European Commission to EFSA received on 4 August 2016 for the continued
marketing of genetically modiﬁed maize 59122 in accordance with articles 11 and 23 of
Regulation (EC) No 1829/2003 by Pioneer Overseas Corporation and Dow AgroSciences Ltd.
(EFSA-GMO-RX-003).
2) Acknowledgement letter dated 30 August 2016 from EFSA to European Commission.
3) Letter from EFSA to applicant dated 16 September 2016 delivering the ‘Statement of
Validity’ for application EFSA-GMO-RX-003.
4) Letter from EFSA to applicant dated 24 October 2016 requesting additional information and
stopping the clock.
5) Letter from EFSA to applicant dated 29 November 2016 requesting additional information
and maintaining the clock stopped.
6) Letter from applicant to EFSA received on 2 December 2016 asking for an extension of
deadline to submit information requested on 24 October 2016.
7) Letter from applicant to EFSA received on 5 January 2017 accepting the request for
additional information and deadline of EFSA letter dated 29 November 2016.
8) Email from EFSA to applicant accepting the extension of deadline requested on 2 December
2016.
9) Letter from applicant to EFSA received on 23 January 2017 providing additional information
following EFSA request of 24 October 2016.
10) Email from EFSA to applicant of 24 January 2017 acknowledging receipt of additional
information and informing that clock remains stopped.
11) Letter from applicant to EFSA received on 26 January 2017 providing additional information
following EFSA request of 29 November 2016.
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Email from EFSA to applicant of 26 January 2017 acknowledging receipt of additional information
and restarting the clock.
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